Susan Hasty, Publisher
Table of Contents . . . April 5th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
Drug Development - Cell-penetrating, Rev-binding peptides can protect against HIV
Drug Development - Fungal derivatives show promise as HIV integrase inhibitors
Drug Development - Novel benzophenones show promise as anti-HIV NNRTIs
HIV/AIDS Therapy - Hepatotoxic effects comparable for all ARVs
HIV/AIDS Therapy - Routine resistance testing can improve ART outcome in experienced patients
HIV/AIDS Women's Health - Vitamin A supplements may increase risk of vertical HIV transmission
Brain Cancer - Ritonavir treatment may benefit glioblastoma patients
Breast Cancer - Caelyx demonstrates efficacy, reduced cardiac toxicity
Drug Development - Betulonic acid-based agents active against HIV, influenza A, other viruses
Finance - Biotechnology company completes $23.1M series B financing
Finance - Vaccine development helps drive company's 25% revenue increase in 2003
Genomics & Genetics - Vestigial theta-defensin pseudogenes identified in humans
HIV Exposure - Quebec calls 1200 people for HIV tests, acupuncture clinic reused needles
HIV/AIDS - Canada's Foreign Minister says AIDS crisis has become a human rights issue
HIV/AIDS - Ohio AIDS center to close due to dwindling donations
HIV/AIDS - U.N. plan to treat HIV/AIDS sufferers endangered by lack of money
HIV/AIDS Dementia - Soluble Fas levels in CSF correlate with HIV dementia severity
HIV/AIDS Education - AIDS awareness educators reach out to secretive gay Arab community
HIV/AIDS Opportunistic Infection - First Mycobacterium haemophilum infection in AIDS patient in Italy reported
HIV/AIDS Opportunistic Infection - Novel Cryptococcus species isolated from AIDS patients
HIV/AIDS Prevention - AIDS prevention programs get $47 million infusion from Gates Foundation
HIV/AIDS Proteins - Membrane-active gp41 regions identified
HIV/AIDS Therapy - Impact of HCV coinfection on risk of HAART-induced liver damage reviewed
HIV/AIDS Therapy - Mitochondrial-to-nuclear DNA ratio may mark mitochondrial toxicity
HIV/AIDS Therapy - NIH grant to fund drug development for multidrug-resistant HIV
HIV/AIDS Therapy - Untimed drug levels powerful tool for measuring treatment compliance
HIV/AIDS Vaccine - High-mannose-type oligosaccharides bind to human antibody 2G12
HIV/AIDS Vertical Transmission - HIV p24 antigen test can detect subtype G strains
HIV/AIDS Women's Health - Antiretroviral therapy does not prevent HPV-induced genital lesions
HIV/HCV Coinfection - IFN-alpha with ribavirin can suppress virus-specific immunity
Immunology - Adaptive regulatory T cells suppress killing of persistently infected cells
Immunology - Data presented on molecular mechanism of action for HE2000
Immunology - Effects of morphine on HIV gp160-induced monocyte apoptosis clarified
Immunology - Similarities between HIV infection and aging may aid fight against both
Legal Issues - Rhode Island doctor found guilty of diluting vaccines
Occupational Health - Doctors call for balancing of patient/worker viral transmission protection
Personnel - Bosko Djordjevic elected to board of directors
Poliomyelitis Vaccine - Controversial polio vaccines are safe, Nigerian president says
Psychosocial Issues - Returning to work is difficult for men with HIV/AIDS
Public Health - Hispanics face significant disparities in pharmaceutical treatment
Quality Assurance - Company announces an upgrade to ISO 9001:2000 certification
Simian Foamy Virus - Study confirms transmission of retrovirus
Supplement - JUVEN added to Ross Products' line
Tuberculosis Prevention - New TB vaccine now in Phase I tests
Tuberculosis Therapy - Rifamycin resistance risk similar for rifampin and rifabutin DOT regimens
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.